Jane Street
NVCR icon

Jane Street’s NovoCure NVCR Stock Holding History

Jane Street’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$373K Buy
+34,200
New +$427K ﹤0.01% 8734
2025
Q3 		– Sell
-25,600
Closed -$456K – 11463
2025
Q2 		$456K Buy
+25,600
New +$446K ﹤0.01% 7102
2025
Q1 		– Sell
-32,700
Closed -$974K – 10252
2024
Q4 		$974K Buy
+32,700
New +$692K ﹤0.01% 5447
2024
Q2 		– Sell
-10,500
Closed -$164K – 9940
2024
Q1 		$164K Sell
10,500
-223,100
-96% -$3.28M ﹤0.01% 8291
2023
Q4 		$3.49M Buy
233,600
+164,500
+238% +$2.2M ﹤0.01% 3387
2023
Q3 		$1.12M Sell
69,100
-327,600
-83% -$9.45M ﹤0.01% 5017
2023
Q2 		$16.5M Buy
396,700
+234,800
+145% +$14.6M 0.01% 1411
2023
Q1 		$9.74M Buy
161,900
+28,600
+21% +$2.29M ﹤0.01% 1673
2022
Q4 		$9.78M Buy
133,300
+48,400
+57% +$3.64M ﹤0.01% 1645
2022
Q3 		$6.45M Buy
84,900
+33,000
+64% +$2.57M ﹤0.01% 2237
2022
Q2 		$3.61M Sell
51,900
-11,500
-18% -$866K ﹤0.01% 3154
2022
Q1 		$5.25M Sell
63,400
-9,800
-13% -$722K ﹤0.01% 2948
2021
Q4 		$5.5M Buy
73,200
+7,800
+12% +$783K ﹤0.01% 2707
2021
Q3 		$7.6M Buy
65,400
+41,200
+170% +$6.23M ﹤0.01% 2168
2021
Q2 		$5.37M Sell
24,200
-7,400
-23% -$1.44M ﹤0.01% 2527
2021
Q1 		$4.18M Sell
31,600
-28,300
-47% -$4.48M ﹤0.01% 2674
2020
Q4 		$10.4M Buy
59,900
+1,700
+3% +$233K 0.01% 1388
2020
Q3 		$6.48M Buy
58,200
+13,200
+29% +$1.06M ﹤0.01% 1594
2020
Q2 		$2.67M Buy
45,000
+39,800
+765% +$2.62M ﹤0.01% 2665
2020
Q1 		$350K Sell
5,200
-200
-4% -$15.8K ﹤0.01% 4035
2019
Q4 		$455K Sell
5,400
-5,100
-49% -$412K ﹤0.01% 3801
2019
Q3 		$785K Buy
+10,500
New +$840K ﹤0.01% 2933

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Jane Street's NVCR Position: Q1 2026 in Review

Jane Street sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 319,814 shares — an estimated $3.99M sold.

Jane Street first reported a position in NVCR in Q4 2017 and held it in 27 quarters. The position peaked at $21.9M in Q2 2023. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Jane Street reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 319,814 NovoCure shares in Q1 2026, an estimated $3.99M.
  • Jane Street first reported a position in NovoCure in Q4 2017 and held it in 27 quarters.
  • Jane Street's NovoCure position peaked at $21.9M in Q2 2023.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.